National Pregnancy Registry for Antidepressants

National Pregnancy Registry for Antidepressants 2018-05-29T18:05:42+00:00

The National Pregnancy Registry for Antidepressants (NPRAD) is dedicated to evaluating the safety of antidepressant medications that may be taken by women during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy for both mother and child.


All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry. If you are interested in participating in the National Pregnancy Registry, please call the toll-free number above or fill out this Patient Interest Form to be contacted by a member of our research team. All information is kept strictly confidential.

More Information and Enrollment:

Declined to sponsor: Edgemont Pharmaceutical, Takeda Pharmaceuticals

Funding Information: Manufacturers of branded antidepressants have been approached regarding funding of the National Pregnancy Registry for Antidepressants. Regardless of which entities have supported this initiative, all medications in this class are studied. For more information on how to sponsor the Registry, please see the contact information below.

Call Toll-Free: 1-844-405-6185